Sixgill, LLC, the leader in sensor data services for governing Internet of Everything (IoE) assets, today announced Litmus Health will adopt Sixgill Integrity to provide blockchain data accuracy and consistency for its clinical data science platform. The combination...
Atlanta-based FusionHealth announced today a new research collaboration with the University of Michigan for a clinical trial called Sleep SMART (Sleep for Stroke Management and Recovery Trial), during which researchers will investigate whether obstructive sleep apnea...
Grant funding by The Michael J. Fox Foundation will support Phase 2 trial Alkahest, Inc., a clinical-stage biotechnology company focused on developing innovative therapies to treat age-related diseases, today announced dosing of the first subject in a Phase 2 clinical...
Trialbee, a global provider of best-in-class digital patient recruitment and engagement solutions for clinical research, announces the official release of its digital patient engagement solutions. With Trialbee, sponsors, CROs and investigator sites can increase...
Veru Inc. (NASDAQ: VERU), an oncology and urology biopharmaceutical company, announced today that the Company has dosed its first patient for its bioequivalence study of Tadalafil (Cialis®) and Finasteride (PROSCAR®) combination tablet for benign prostatic hyperplasia...
Email
Text